Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5964
    +0.0028 (+0.47%)
     
  • NZD/EUR

    0.5557
    +0.0011 (+0.20%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    83.00
    +0.19 (+0.23%)
     
  • GOLD

    2,339.00
    +0.60 (+0.03%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,097.84
    +57.46 (+0.71%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,002.66
    -86.04 (-0.48%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.7910
    +0.6760 (+0.73%)
     

Analysts’ March 2018 Ratings for Baxter International and Peers

Analysts’ March 2018 Ratings for Baxter International and Peers

Who Is Watching Baxter International in March 2018? Baxter International’s (BAX) top-line performance in 4Q17 was mainly driven by increased demand for the company’s Fluid Systems’ products. Baxter International also witnessed rising demand for its cytotoxic contract manufacturing services.